Acute myeloid leukemia in the elderly: therapeutic options and choice
2017 · Leukemia & lymphoma/Leukemia and lymphoma · 81 citations
https://doi.org/10.1080/10428194.2017.1330956
J
Jonathan Webster
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
187
Papers
4.5K
Citations
32
h-index
61
i10-index
Jonathan Webster is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 32, co-authored 159 publications.
ORCID: 0000-0003-3647-6345Papers by this author
worksMulti-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (≥65 Years) AML Patients
2019 · Blood · 69 citations
https://doi.org/10.1182/blood-2019-127345
Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis
2012 · Journal of Biological Chemistry · 56 citations
https://doi.org/10.1074/jbc.m112.371229
Mobile app validation: a digital health scorecard approach
2021 · npj Digital Medicine · 41 citations
https://doi.org/10.1038/s41746-021-00476-7
Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML
2019 · Blood · 33 citations
https://doi.org/10.1182/blood-2019-126065
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults
2025 · Blood Cancer Journal · 5 citations
https://doi.org/10.1038/s41408-025-01350-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat